{
    "Trade/Device Name(s)": [
        "SmartLyte\u00ae Plus Electrolyte Analyzer Na+/K+/Cl-/Ca++/Li+"
    ],
    "Submitter Information": "Diamond Diagnostics, Inc.",
    "510(k) Number": "K200544",
    "Predicate Device Reference 510(k) Number(s)": [
        "K082462"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CEM",
        "JGS",
        "CGZ",
        "JFP",
        "JIH",
        "JJE"
    ],
    "Summary Letter Date": "August 12, 2020",
    "Summary Letter Received Date": "September 1, 2020",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1665",
        "21CFR862.1600",
        "21CFR862.1170",
        "21CFR862.1145",
        "21CFR862.3560",
        "21CFR862.2160"
    ],
    "Regulation Name(s)": [
        "Sodium Test System",
        "Potassium Test System",
        "Chloride Test System",
        "Calcium Test System",
        "Lithium Test System",
        "Discrete photometric chemistry analyzer for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "tdm"
    ],
    "Analyte(s)": [
        "Sodium",
        "Potassium",
        "Chloride",
        "Calcium",
        "Lithium"
    ],
    "Specimen Type(s)": [
        "Venous Whole Blood",
        "Serum",
        "Sodium Heparin Plasma",
        "Urine",
        "Aqueous QC"
    ],
    "Specimen Container(s)": [
        "Sodium Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "SmartLyte\u00ae Plus Electrolyte Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Ion-selective electrode"
    ],
    "Methodologies": [
        "Potentiometric measurement"
    ],
    "Submission Type(s)": [
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for Diamond Diagnostics SmartLyte\u00ae Plus Electrolyte Analyzer measuring sodium, potassium, chloride, calcium, and lithium via ion-selective electrodes in blood, plasma, serum, and urine.",
    "Indications for Use Summary": "Automated analyzer for in-vitro measurement of sodium, potassium, chloride, calcium, and lithium in serum, sodium heparin plasma, venous whole blood, and sodium, potassium, and chloride in pre-diluted urine to aid diagnosis and monitoring of electrolyte and metabolic disorders, parathyroid and bone diseases, renal disease, drug (lithium) regulation, and related conditions.",
    "fda_folder": "Clinical Chemistry"
}